Sinovac Biotech. Ltd. (SVA) Begins H1N1 testing program in China, Enters into Agreement with Philippine Distributor

By Jonathan
30 July 2009 @ 06:13 am EDT

Some products provide solutions to global issues. These products are often more a need rather than a want. Being able to capitalize on this unfortunate reality is the key. Of course management needs to be cognizant of the moral questions that go along with these types of products, but the opportunity to make some revenue while benefitting the world population can be justified in the course of normal events. Currently there are two issues that might fit into this type of mold, global warming and the H1N1 flu pandemic.

Small Cap News in collaboration with Quality Stocks

E-Newsletters

We value your privacy. Your email address will not be shared.